Lung cancer
Lung cancer
05/30/2017
The FDA has broadened the approval of a non-small cell lung cancer drug, previously approved in 2014.
05/30/2017
Lung cancer
Lung cancer
05/30/2017
The FDA has broadened the approval of a non-small cell lung cancer drug, previously approved in 2014.
05/30/2017
Lung cancer
Lung cancer
05/30/2017
The FDA has broadened the approval of a non-small cell lung cancer drug, previously approved in 2014.
05/30/2017
Rheumatoid Arthritis
Rheumatoid Arthritis
05/23/2017
After successful testing, a new treatment for rheumatoid arthritis has been approved by the US Food and Drug Administration.
05/23/2017
Rheumatoid Arthritis
Rheumatoid Arthritis
05/23/2017
After successful testing, a new treatment for rheumatoid arthritis has been approved by the US Food and Drug Administration.
05/23/2017
Rheumatoid Arthritis
Rheumatoid Arthritis
05/23/2017
After successful testing, a new treatment for rheumatoid arthritis has been approved by the US Food and Drug Administration.
05/23/2017
Vasculitis
Vasculitis
05/22/2017
The FDA has approved the first drug specifically approved for the treatment of a type of vasculitis with previously limited treatment options.
05/22/2017
Vasculitis
Vasculitis
05/22/2017
The FDA has approved the first drug specifically approved for the treatment of a type of vasculitis with previously limited treatment options.
05/22/2017
Vasculitis
Vasculitis
05/22/2017
The FDA has approved the first drug specifically approved for the treatment of a type of vasculitis with previously limited treatment options.
05/22/2017
Urology
Urology
05/18/2017
The FDA has approved a new option for the treatment of patients with locally advanced or metastatic urothelial carcinoma.
05/18/2017